about
RNA mediated Toll-like receptor stimulation in health and diseasePattern recognition receptors as potential therapeutic targets in inflammatory rheumatic diseaseThe Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate ImmunityPolarization of host immune responses by helminth-expressed glycansA Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent PathwayGene expression studies of a human monocyte cell line identify dissimilarities between differently manufactured glatiramoidsIdentification of pro-inflammatory CD205+ macrophages in livers of hepatitis B virus transgenic mice and patients with chronic hepatitis B.Therapeutic Boosting of the Immune Response: Turning to CD14 for Help.A human monocytic NF-κB fluorescent reporter cell line for detection of microbial contaminants in biological samplesRecombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligandsNovel synthetic toll-like receptor 4/MD2 ligands attenuate sterile inflammationAPOε4 is associated with enhanced in vivo innate immune responses in human subjectsCD14 influences host immune responses and alternative activation of macrophages during Schistosoma mansoni infectionHuman cytomegalovirus induces TLR4 signaling components in monocytes altering TIRAP, TRAM and downstream interferon-beta and TNF-alpha expression.Vascular dysfunction following polymicrobial sepsis: role of pattern recognition receptorsTLR9 activation is triggered by the excess of stimulatory versus inhibitory motifs present in Trypanosomatidae DNA.No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritisRespiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodiesTLR2 ligands induce NF-κB activation from endosomal compartments of human monocytesPorphyromonas gingivalis gingipains selectively reduce CD14 expression, leading to macrophage hyporesponsiveness to bacterial infection.Emerging principles governing signal transduction by pattern-recognition receptorsAlterations of dendritic cells in sepsis: featured role in immunoparalysis.CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancerToll-like receptor 4 activation in cancer progression and therapyLipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1α Release.CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin toleranceMechanisms and pathways of innate immune activation and regulation in health and cancer.TACI deficiency leads to alternatively activated macrophage phenotype and susceptibility to Leishmania infection.Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humansNon-CpG Oligonucleotides Exert Adjuvant Effects by Enhancing Cognate B Cell-T Cell Interactions, Leading to B Cell Activation, Differentiation, and Isotype Switching.Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14.Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells.DEC-205 is a cell surface receptor for CpG oligonucleotides.Toll-like Receptors in the Vascular System: Sensing the Dangers Within.CD19 controls Toll-like receptor 9 responses in human B cellsCD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers.Combined Inhibition of Complement and CD14 Attenuates Bacteria-Induced Inflammation in Human Whole Blood More Efficiently Than Antagonizing the Toll-like Receptor 4-MD2 Complex.Toll-like receptor 9 promotes cardiac inflammation and heart failure during polymicrobial sepsisToll-like receptor and accessory molecule mRNA expression in humans and mice as well as in murine autoimmunity, transient inflammation, and progressive fibrosisModulation of murine macrophage TLR7/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium.
P2860
Q26999252-2679EA0A-0035-494D-B463-F1B1A6BA66FBQ28084262-1545ADDC-4D52-4AA6-9F10-28DBF577801FQ28115270-EBAEB6AE-AD29-400B-9FCD-38EF97122989Q28274980-5430F7B5-BF2D-4D0F-9216-190B403B4867Q28547758-E6E75E72-8CDB-485E-8F53-1EB7010AF1F4Q28647160-939179A2-559A-4A93-9B37-4961C6D2DB46Q33594263-B785B5BC-FE8A-4960-91E2-BEB79436EF22Q33646535-F6D05F01-75DC-4915-9E49-6C8A9D1AEBB4Q33724996-A89683FD-66CA-4683-B380-A4DCF0643929Q33906000-F5954A90-C494-415B-926B-C78ADF913C2DQ33944008-31313E9E-A967-49F3-AA98-EC8EB1DE146BQ34017080-52D80591-8951-4859-BD63-B4D1D65729B9Q34059017-55B506EC-03CB-4406-9E7D-48ED878FE539Q34412487-F51A172C-45F1-4E8B-BCC8-FE6CC569D4C3Q34412514-B73F26FE-C975-447C-969A-3A02FDD1DB91Q34505652-EA157831-AB94-4117-A8A7-E73551CDCCC7Q34764677-56FDA359-0793-4B63-85F2-4F62E5A93711Q35058641-223D6E87-6856-48EF-B900-FC8F4C8F66F7Q35069416-F4FE2726-8459-4991-989B-8E2ACD4BA930Q35142987-1FD47A3A-CA1D-4F6B-87B6-B21126FE19C4Q35164313-CFF378C9-8983-4E25-A212-7E552A0787F7Q35188317-F4848DE2-2269-4E81-A956-A5B0D7B7F5B9Q35485418-F2DE91DE-A24B-444A-A9C2-8528E50EFA21Q35550677-60B80A62-10AE-4C32-8686-0CD4ECC52FDEQ35581200-6E37F85F-670D-43E0-9113-842877594063Q35845957-D3AAE00F-7CE5-4FB4-8A38-B633340A0470Q35886583-CACDEE27-2AC7-482C-B574-D195EB537B1CQ35910201-F4E9DBB4-E475-4FCC-9D1A-B1EC5A65F563Q35987250-99BCAD9A-BCE1-4D65-827D-B21A187DC06DQ36034711-7392EDFC-12E4-4824-844A-6FAA41C86379Q36066963-2603FD35-33C1-4C9F-AF31-4C358E9D62CAQ36098032-EAD2EB1E-F63E-4866-B0F4-B887F9D70030Q36343007-8894D60C-CBB5-4E60-B928-16428123757CQ36453194-5F39378C-D136-4F3A-8D2A-5AE379EEA7EEQ36665253-DEC7B969-9DD2-4CFA-BD23-4B57E09CC79AQ36850259-573373D5-0A33-4B31-9313-9D38303E4679Q37003067-607F3035-A59F-4807-890E-32A4358C0846Q37019795-C4566301-91C8-4BEC-B064-7F7AB530EF06Q37091783-75C575F8-3B8A-439C-9E79-42C3A3B472A3Q37245154-165DE279-A6BD-4166-945D-98BC66FA76FB
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@ast
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@en
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@nl
type
label
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@ast
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@en
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@nl
prefLabel
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@ast
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@en
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@nl
P2093
P2860
P50
P356
P1476
CD14 is a coreceptor of Toll-like receptors 7 and 9.
@en
P2093
Andreas Pichlmair
Christoph L Baumann
Irene M Aspalter
Jacques Colinge
Karin Aumayr
Keiryn L Bennett
Manuela Bruckner
Melanie Planyavsky
Pawel Pasierbek
Stephan Blüml
P2860
P304
P356
10.1084/JEM.20101111
P407
P577
2010-11-15T00:00:00Z